We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$5.37M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.7M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.54M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12M
5
NVDA icon
NVIDIA
NVDA
+$1.88M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.88M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$4.62M
3
OCSL icon
Oaktree Specialty Lending
OCSL
+$825K
4
MGI
MoneyGram International, Inc. New
MGI
+$627K
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$562K

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBSW icon
2401
Sibanye-Stillwater
SBSW
$7.53B
$836 ﹤0.01%
134
-97
-42% -$765
VMEO
2402
DELISTED
Vimeo
VMEO
$836 ﹤0.01%
203
– –
NSSC icon
2403
Napco Security Technologies
NSSC
$1.48B
$832 ﹤0.01%
24
– –
MAXN
2404
DELISTED
Maxeon Solar Technologies
MAXN
– –
0
– –
LICY
2405
DELISTED
Li-Cycle Holdings Corp.
LICY
$816 ﹤0.01%
18
-50
-74% -$2.04K
BSRR icon
2406
Sierra Bancorp
BSRR
$525M
$815 ﹤0.01%
+48
New +$790
EVO icon
2407
Evotec
EVO
$711M
$814 ﹤0.01%
72
– –
MODV
2408
DELISTED
ModivCare
MODV
$814 ﹤0.01%
18
-56
-76% -$3.33K
ERII icon
2409
Energy Recovery
ERII
$443M
$811 ﹤0.01%
29
– –
NXGN
2410
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$811 ﹤0.01%
50
-46
-48% -$762
EWZ icon
2411
iShares MSCI Brazil ETF
EWZ
$8.95B
$805 ﹤0.01%
25
– –
IIPR icon
2412
Innovative Industrial Properties
IIPR
$1.72B
$803 ﹤0.01%
11
– –
ARQT icon
2413
Arcutis Biotherapeutics
ARQT
$3.18B
$801 ﹤0.01%
+84
New +$932
TPH
2414
DELISTED
Tri Pointe Homes
TPH
$789 ﹤0.01%
24
– –
CRSP icon
2415
CRISPR Therapeutics
CRSP
$5.17B
$786 ﹤0.01%
14
-23
-62% -$1.3K
PLTK icon
2416
Playtika
PLTK
$1.12B
$777 ﹤0.01%
67
– –
NWN icon
2417
Northwest Natural Holdings
NWN
$2.12B
$775 ﹤0.01%
18
-24
-57% -$1.08K
UNF icon
2418
Unifirst Corp
UNF
$5.25B
$775 ﹤0.01%
5
-32
-86% -$5.38K
ELME
2419
Elme Communities
ELME
$144M
$773 ﹤0.01%
+47
New +$776
ACA icon
2420
Arcosa
ACA
$7.11B
$758 ﹤0.01%
10
-4
-29% -$269
AGYS icon
2421
Agilysys
AGYS
$3.06B
$755 ﹤0.01%
11
– –
TIL icon
2422
Instil Bio
TIL
$50.3M
$755 ﹤0.01%
69
– –
VREX icon
2423
Varex Imaging
VREX
$523M
$754 ﹤0.01%
+32
New +$666
ICFI icon
2424
ICF International
ICFI
$1.72B
$746 ﹤0.01%
6
– –
PZZA icon
2425
Papa John's
PZZA
$806M
$738 ﹤0.01%
10
-46
-82% -$3.41K
95 96
97
98 99

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.